Supernus Pharmaceuticals Overview
Supernus Pharmaceuticals Target Price
Analysts' 12-month price predictions for SUPN.
Share Price
$31.16
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-09-11 | Piper SandlerDavid Amsellem | $36 |  15.5% upside |  |
| 2024-05-24 | Piper SandlerDavid Amsellem | $41 | 31.6% upside | |
| 2024-04-08 | JefferiesIrene Buhalo | $40 | 28.4% upside | |
| 2024-04-08 | Stifel NicolausAnnabel Samimy | $38 | 22% upside | |